Biogen (BIIB) PT Lowered to $343 at Wells Fargo

August 7, 2023 6:15 AM

Wells Fargo analyst Mohit Bansal lowered the price target on Biogen (NASDAQ: BIIB) to $343.00 (from $350.00) while maintaining a Overweight rating.

No results found